Deferoxamine 500 mg/vial, 2 g/vial Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for injection
Available Strengths: 500 mg/vial, 2 g/vial
Reference Brands: Desferal
Category: Anemia
Deferoxamine (Desferal) treats acute and chronic iron overload. Available in 500 mg and 2 g vials. Trusted for B2B pharma supply globally.
Product Description:
Deferoxamine (Desferal®) is a trusted parenteral iron chelator used in the treatment of acute iron poisoning and chronic iron overload due to frequent blood transfusions, especially in thalassemia and sickle cell disease. Available as 500 mg and 2 g lyophilized powder for injection, it is administered via IV, IM, or subcutaneous infusion. Marketed under the brand Desferal in the US and EU, it’s manufactured under GMP-compliant standards for hospital and clinical use. Ideal for global B2B pharmaceutical procurement. Contact us for bulk export, COAs, and regulatory support documents.
Deferoxamine — third party manufacturing & bulk supply
Deferoxamine 500 mg/vial, 2 g/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Deferoxamine is supplied as Lyophilized powder for injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Deferoxamine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Deferoxamine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Deferoxamine is used to treat chronic iron overload caused by repeated blood transfusions, commonly seen in conditions like thalassemia, sickle cell disease, and certain anemias. It is also used for acute iron poisoning. It works by binding excess iron and helping the body eliminate it.
Deferoxamine is made from the active compound deferoxamine mesylate, a chelating agent that binds free iron and forms a stable complex that can be excreted from the body.
Deferoxamine is marketed under trade names such as Desferal and other region-specific brands.
Major manufacturers include Novartis (producer of Desferal) and several licensed pharmaceutical companies in different regions who produce generic formulations.
The generic name of the product is deferoxamine mesylate.
It is available under brand names such as Desferal, with additional region-specific branded generics depending on the market.
Deferoxamine is manufactured in multiple countries including Switzerland, the United States, and India, depending on the pharmaceutical company producing it. The exact manufacturing location varies by manufacturer.
Related Products
Mitapivat Sulfate
Strength:
5 mg, 20 mg, 50 mg
Form: Tablets
Reference Brands: Pyrukynd (USA)
View Details
Eltrombopag Cholin 50 Mg Tablet
Strength:
12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
View Details
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
